Answers are grounded in this paper and cite their sources.
Fluorometric detection of nitrosamines in active pharmaceutical ingredients reveals rapid screening potential.
Nitrosamines are genotoxic, mutagenic impurities and widely encountered in the global landscape of the pharmaceutical industry. There is a need for rapid detection of nitrosamines in a pharmaceutical product. Here...
No takes yet. Share an insight, caveat, or question.
Gayathri et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: